Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (apre una nuova finestra)

Ball AM, Winstead PS.

Fonte‎: Pharmacotherapy 2008;28(11):1383-90.

Indicizzato‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (apre una nuova finestra)

Severe acute anemia after liver transplantation in an elderly Jehovah's Witness treated with high-dose erythropoietin and ferric carboxymaltose: a case report. (apre una nuova finestra)

Brunetta DM, Kaufman J, De Santis GC, Mesquita DF, Souza FN, Garcia JH.

Fonte‎: Transplant Proc 2015;47(8):2548-51.

Indicizzato‎: PubMed 26518969

DOI‎: 10.1016/j.transproceed.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26518969 (apre una nuova finestra)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (apre una nuova finestra)

Charles A, Purtill M, Napolitano LM.

Fonte‎: Anaesth Intensive Care 2006;34(6):793-6.

Indicizzato‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (apre una nuova finestra)

Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial. (apre una nuova finestra)

Corwin HL, Gettinger A, Rodriguez RM, Pearl RG, Gubler KD, Enny C, Colton T, Corwin MJ.

Fonte‎: Crit Care Med 1999;27(11):2346-50.

Indicizzato‎: PubMed 10579246

https://www.ncbi.nlm.nih.gov/pubmed/10579246 (apre una nuova finestra)

The role of erythropoietin therapy in the critically ill. (apre una nuova finestra)

Corwin HL.

Fonte‎: Transfus Med Rev 2006;20(1):27-33.

Indicizzato‎: PubMed 16373185

DOI‎: 10.1016/j.tmrv.2005.08.002

https://www.ncbi.nlm.nih.gov/pubmed/16373185 (apre una nuova finestra)

Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. (apre una nuova finestra)

Georgopoulos D, Matamis D, Routsi C, Michalopoulos A, Maggina N, Dimopoulos G, Zakynthinos E, Nakos G, Thomopoulos G, Mandragos K, Maniatis A; Critical Care Clinical Trials Greek Group.

Fonte‎: Crit Care 2005;9(5):R508-15.

Indicizzato‎: PubMed 16277712

DOI‎: 10.1186/cc3786

https://www.ncbi.nlm.nih.gov/pubmed/16277712 (apre una nuova finestra)

Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. (apre una nuova finestra)

Khalafallah AA, Yan C, Al-Badri R, Robinson E, Kirkby BE, Ingram E, Gray Z, Khelgi V, Robertson IK, Kirkby BP.

Fonte‎: Lancet Haematol 2016;3(9):e415-25.

Indicizzato‎: PubMed 27570088

DOI‎: 10.1016/S2352-3026(16)30078-3

https://www.ncbi.nlm.nih.gov/pubmed/27570088 (apre una nuova finestra)

Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis. (apre una nuova finestra)

Mesgarpour B, Heidinger BH, Schwameis M, Kienbacher C, Walsh C, Schmitz S, Herkner H.

Fonte‎: Intensive Care Med 2013;39(11):1896-908.

Indicizzato‎: PubMed 23928897

DOI‎: 10.1007/s00134-013-3030-9

https://www.ncbi.nlm.nih.gov/pubmed/23928897 (apre una nuova finestra)

An international consensus statement on the management of postoperative anaemia after major surgical procedures. (apre una nuova finestra)

Muñoz M, Acheson AG, Bisbe E, Butcher A, Gómez-Ramírez S, Khalafallah AA, Kehlet H, Kietaibl S, Liumbruno GM, Meybohm P, Rao Baikady R, Shander A, So-Osman C, Spahn DR, Klein AA

Fonte‎: Anaesthesia 2018;73(11):1418-31.

Indicizzato‎: PubMed 30062700

DOI‎: 10.1111/anae.14358

https://www.ncbi.nlm.nih.gov/pubmed/30062700 (apre una nuova finestra)

How do we treat life-threatening anemia in a Jehovah's Witness patient? (apre una nuova finestra)

Posluszny JA Jr, Napolitano LM.

Fonte‎: Transfusion 2014;54(12):3026-34.

Indicizzato‎: PubMed 25330835

DOI‎: 10.1111/trf.12888

https://www.ncbi.nlm.nih.gov/pubmed/25330835 (apre una nuova finestra)

Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. (apre una nuova finestra)

Price S, Pepper JR, Jaggar SI.

Fonte‎: Anesth Analg 2005;101(2):325-7.

Indicizzato‎: PubMed 16037136

DOI‎: 10.1213/01.ANE.0000159158.70532.D0

https://www.ncbi.nlm.nih.gov/pubmed/16037136 (apre una nuova finestra)

Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. (apre una nuova finestra)

Ranucci M, Baryshnikova E, Crapelli GB, Rahe-Meyer N, Menicanti L, Frigiola A; Surgical Clinical Outcome REsearch (SCORE) Group.

Fonte‎: J Am Heart Assoc 2015;4(6):e002066.

Indicizzato‎: PubMed 26037084

DOI‎: 10.1161/JAHA.115.002066

https://www.ncbi.nlm.nih.gov/pubmed/26037084 (apre una nuova finestra)

Life-threatening postoperative blood loss in a Jehovah's Witness, treated with high-dose erythropoietin. (apre una nuova finestra)

Schälte G, Janz H, Busse J, Jovanovic V, Rossaint R, Kuhlen R.

Fonte‎: Br J Anaesth 2005;94(4):442-4.

Indicizzato‎: PubMed 15653706

DOI‎: 10.1093/bja/aei068

https://www.ncbi.nlm.nih.gov/pubmed/15653706 (apre una nuova finestra)

Transfusion-free management of gastrointestinal bleeding: the experience of a Bloodless Institute. (apre una nuova finestra)

Sharma P, Barajas FJ, Krishnamoorthy P, Campo LM, Blumenthal E, Spinnell M.

Fonte‎: J Clin Gastroenterol 2015;49(3):206-11.

Indicizzato‎: PubMed 25144897

DOI‎: 10.1097/MCG.0000000000000200

https://www.ncbi.nlm.nih.gov/pubmed/25144897 (apre una nuova finestra)

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. (apre una nuova finestra)

Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL.

Fonte‎: Crit Care Med 2006;34(9):2310-6.

Indicizzato‎: PubMed 16878035

DOI‎: 10.1097/01.CCM.0000233873.17954.42

https://www.ncbi.nlm.nih.gov/pubmed/16878035 (apre una nuova finestra)